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Abstract
Background: Ribosomal RNA (rRNA) is a central regulator of cell growth and may control cancer development. A cis
noncoding rRNA (nc-rRNA) upstream from the 45S rRNA transcription start site has recently been implicated in control of
rRNA transcription in mouse fibroblasts. We investigated whether a similar nc-rRNA might be expressed in human cancer
epithelial cells, and related to any genomic characteristics.
Methodology/Principal Findings: Using quantitative rRNA measurement, we demonstrated that a nc-rRNA is transcribed in
human lung epithelial and lung cancer cells, starting from approximately 21000 nucleotides upstream of the rRNA
transcription start site (+1) and extending at least to +203. This nc-rRNA was significantly more abundant in the majority of
lung cancer cell lines, relative to a nontransformed lung epithelial cell line. Its abundance correlated negatively with total
45S rRNA in 12 of 13 cell lines (P=0.014). During sequence analysis from 2388 to +306, we observed diverse, frequent
intercopy single nucleotide polymorphisms (SNPs) in rRNA, with a frequency greater than predicted by chance at 12 sites. A
SNP at +139 (U/C) in the 59 leader sequence varied among the cell lines and correlated negatively with level of the nc-rRNA
(P=0.014). Modelling of the secondary structure of the rRNA 59-leader sequence indicated a small increase in structural
stability due to the +139 U/C SNP and a minor shift in local configuration occurrences.
Conclusions/Significance: The results demonstrate occurrence of a sense nc-rRNA in human lung epithelial and cancer cells,
and imply a role in regulation of the rRNA gene, which may be affected by a +139 SNP in the 59 leader sequence of the
primary rRNA transcript.
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Introduction
Synthesis of ribosomes demands a high proportion of cellular
resources and hence is highly regulated. Biogenesis of the 45S
ribosomal RNA (rRNA) is rate-limiting for ribosome synthesis
and is closely controlled at multiple levels. An increase in
ribosomes is a common feature of actively proliferating cells,
including cancer cells, may be inducible by oncogene activation
or inactivation of tumor suppressors, and may even be cancer-
causative [1,2].
A new type of rRNA regulator has recently been discovered in
mouse fibroblasts: a sense non-coding RNA (nc-rRNA) originat-
ing from the intergenic spacer region between rRNA tandemly
repeated genes.It was shown to function as a negative regulator
of rRNA expression [3,4]. The possible occurrence and
significance of this nc-rRNA in human cells, in cells of epithelial
origin, and in cancer cells have not been studied. We
investigated whether this nc-rRNA might be found in human
lung epithelial cells and in human lung cancer cells. We also
noted the occurrence of single nucleotide polymorphisms (SNPs)
in the rRNA gene among the cell lines, in the sequences upstream
and downstream of the rRNA transcription start site, and studied
their relationships to the nc-rRNA levels and to potential folding
of the rRNA.
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Single nucleotide polymorphisms in rRNA near the
transcription start site
In humans, some 400 rRNA gene copies are arranged in sets of
tandem repeats on 5 chromosomes [5]. The arrangement of the
18S, 5.8S, and 28S rRNA genes is diagrammed in Fig. 1. Their
products are processed from a 45S precursor rRNA, which begins
with a 59-external transcribed sequence; the first 414 nucleotides of
this constitute a leader sequence and is the first part to be removed
[6]. The core promoter is located at approximately 245 to +18
relative to the transcription start site. There are also regulatory
enhancer elements in the intergenic spacers [reviewed in 7].
Six human lung adenocarcinoma cell lines and a nontrans-
formed immortalized line from human peripheral lung epithelium
were studied at the genomic level. For each cell line, 35–65 clones
of amplified products for the region 2388 to +306 (relative to the
+1 transcription start site) were obtained and sequenced. In
comparisons with sequences for an rRNA from chromosome 22
(GenBank AL592188), among the seven cell lines there was at least
one SNP at 329 of the 694 sites (47.4%). Detailed data are given in
Supplementary Table S1. At least one SNP was found in 68% to
90% of the clones from the various cell lines (Table 1). The
percentages were not significantly different among the lines.
Among the SNP-positive clones, the average numbers of SNPs was
2.1 to 3.1, with no significance differences among the cell lines.
The percentages of clones stratified by numbers of SNPs also did
not vary significantly across the cell lines (Table 1).
We determined whether individual sites were more likely to
present a SNP than expected by chance, for all seven cell lines
considered together. Probabilities obtained from the Poisson
distribution indicated that occurrence of SNPs in 6 or more
clones at a given site was highly unlikely (P,0.0001) by chance.
There were 12 such sites (total number of clones in parentheses):
2234 (9), 2233 (10), 2181 (6), 2104 (6), 296 (28), 272 (6), +52
(7), +139 (51), +144 (6), +207 (9), +225 (7), and +290 (6). The
occurrences of these hotspot SNPs in the cell lines are shown in
Table 1. Of these, several are especially notable. Three different
SNPs were found at site 2233 (T/A, T/C, or deletion,
Supplementary Table 1), with at least one SNP in each cell line.
Line A549 had noticeably more SNPs at 296 (22 SNPs) and +139
(28 SNPs), compared with the other cells lines (Table 1). SNP +139
in particular presented high frequency in several lines.
We examined statistically whether there were sequence stretches
where the frequency of SNPs was higher or lower than predicted by
chance. The runs test did not reveal any such stretches for cell lines
A549, H23, H1792, H2030, H2122, and HPL1D and for all of the
lines considered together. However for line H441 considered
separately, the absence of SNPs for the regions 2232 to 2180, and
294 to 226, was not expected by chance alone (P=0.0072).
Several cell lines appeared to exhibit a high frequency of SNPs in
the region 2239 to 2228. The entire region was partitioned into
two strata, a potential SNP hotspot stratum from 2239 to 2228,
and the complementary stratum consisting of the remaining sites.
Poisson regression (with an offset parameter equalling the number
of sites) was used to compare the rates of SNPs in these two strata.
The SNP rate was 3.7 times greater in the potential SNP hotspot
stratum than elsewhere, P=0.0010. The rate increases were
especially prominent for the H1792, HPL1D, and H23 lines: 3.9,
7.3, and 9.0 times greater respectively (all P values#0.0002).
For most cell lines there were several instances of more than one
clone presenting the same SNP(s), in most cases 2 or 3 clones. It
cannot be decided with certainty if these represent separate alleles,
or multiple polymerase chain reaction (PCR) products from the
Figure 1. Repeat unit of the 45S rRNA gene (tandemly repeated
in human chr. 13, 14, 15, 21, and 22). NTS: non-transcribed spacer,
also known as the intergenic region; ETS: external transcribed spacer;
ITS: internal transcribed spacer. rRNA transcription starts at the 59 end of
the ETS, with the first 414 nucleotides comprising the leader sequence.
The non-coding (nc) r-RNA transcript is initiated upstream of the ETS.
doi:10.1371/journal.pone.0007505.g001
Table 1. rRNA SNPs in HPL non-cancer and 6 lung cancer cell lines.
Cell line
Clones with
SNP/total (%)
Av #
SNPs6S.E.
% clones with 1–2,
3–5, or 6+ SNPs Multiple clones with same SNPs Hotspot SNPs
c
1 – 2 3 – 5 6o rm o r e
All lines 282/362 (77.9) 2.560.3 68 27 5 2234(9),2233(10),2181(6),2104(6),296(28),272(6),+52
(7), +139 (51), + 144 (6), +207 (9), +225 (7), +290 (6)
HPL 38/51 (74.5) 2.360.2 71 26 3 +30 & +52 (2)
a +21 & +287 (2) 2234 (4), 2233 (2), 2181 (3), +30 (4), +52 (5), +139 (4)
A549 47/54 (87.0) 2.660.2 53 45 2 296 & +139 (7)
b 296, +139, & 262 (2) 2234, 2233 (2), 2104 (5), 296 (22), +139 (28), +144 (2), +225
H441 29/36 (80.6) 2.360.4 76 17 7 +180 (3), +298 (2) 2233, 2234, +139 (7), +144, +225
H23 43/48 (89.6) 2.560.3 70 23 7 +139 (3), +139 & +213 (2) 2234 (2), 2233 (2), +139 (7), +207 (9), +225 (3)
H1792 41/52 (78.8) 3.160.6 63 27 10 2216 & 240 (2), 2182 & 276 (2) 2234, 2233, 296 (2), 272, +52, +290
H2030 40/56 (71.4) 2.160.3 73 22 5 2110 (2), 273 (2), +290 (3) 2233, 2181 (3), 296 (4), 272 (2), +52, +139 (3), +144 (3),
+290 (3)
H2122 44/65 (67.7) 2.460.2 68 27 5 None 2233, 2104, 272 (3), +139 (2), +225 (2), +290 (2)
a2 additional clones had these SNPs plus 3 or 4 others.
b13 additional clones had these SNPs plus 1 to 4 others.
cOccurrence in each cell line of clones with SNPs that have significant incidence in that cell line, or in all lines considered together. Multiple clones are indicated in
parentheses. Underlined sites are those with a higher number of clones than expected by chance (N$4), in that cell line.
doi:10.1371/journal.pone.0007505.t001
rRNA SNP and Non-Coding RNA
PLoS ONE | www.plosone.org 2 October 2009 | Volume 4 | Issue 10 | e7505same allele. There were 1 to 3 such duplicate pairs in each cell
line, in addition to seven clones in A549 containing both 296 and
+139 SNPs (Table 1). SNP 296 was found only in clones with the
+139 SNP in A549 cells. In addition, there were many instances of
clones with one to three identical SNPs, plus one to many
additional SNPs unique to each clone. These clones obviously
represent different alleles. In each cell line there were 9 to 15 SNP
sites involved in such combinations, except for H441 cells where
only site +139 was found in seven such variant clones. Aside from
the association of SNP 296 with SNP +139 in rRNA clones from
A549 cells, multiple different SNPs appeared to occur at random
in the clones from this and the other cell lines.
In view of the frequency of SNP +139 and the differences among
the cell lines, we examined its occurrence by an additional technique.
RNA was isolated from the seven cell lines listed in Table 1, plus
seven additional lung adenocarcinoma cell lines (Table 2). The
sequence surrounding position +139 was amplified by PCR after
reverse transcription (RT) and the frequency of the two alleles
determined quantitatively by pyrosequencing. The added benefits of
this approach included evaluation of expression of the alleles as
rRNA, and assessment of the wholepopulation ofmolecules,whereas
genomic cloning examined only a random sample. The results
(Table 2) showed good agreement between the two methods. The
correlation between frequency of the +139 SNP in genomic rRNA
(ascertained by cloning) vs that in rRNA (determined by RT-PCR
and pyrosequencing) is significant (P=0.0073), suggesting that both
alleles were equally expressed. Where there were differences in
frequency, e.g. A549 cells, this may be a result of less accuracy in the
estimation of the frequency by the cloning assay.
A non-coding RNA transcribed from rRNA upstream of
the transcription start site
An nc-rRNA from the rRNA intergenic spacer was recently
described for mouse fibroblasts [3,4], but the extent of the original
transcript was not completely defined. Using primers for the region
2244to+203relativetothehumanrRNAtranscriptionstartsite,we
demonstrated that an nc-rRNA for this region was transcribed by
human epithelial cells also, including both the nontransformed
HPL1D cells and lung adenocarcinoma A549 cells (Fig. 2, region I).
The transcript of the nc-rRNA was confirmed by sequencing. To
determine the upstream start site for this nc-rRNA, several primers
were utilized, starting at 21772. Sequencing-confirmed products
wereobtained with primers A–E (21003 to21),whereasprimers F,
G, and H, covering more upstream sequences, showed no products
(Fig. 2). Therefore transcription of the nc-rRNA commenced
between 21225 and 21003.
The amounts of this nc-rRNA varied in the lung cell lines, with
nine adenocarcinoma cell lines exhibiting significantly more than
the nontransformed line HPL1D. One line, A549, had signifi-
cantly less nc-rRNA, and the levels were not significantly different
in three lines (Fig. 3A).
Since in the mouse fibroblast cells the rRNA intergenic spacer
ncRNA had a negative regulatory effect on rRNA [3,4], we
quantified total rRNA with real-time PCR after RT. Relative to
HPL1D, seven cancer lines expressed significantly more rRNA,
two significantly less, and four were not significantly different
(Fig. 3B). For twelve of the thirteen lung cancer cell lines, there was
a significant negative rank correlation between levels of ncRNA
and total rRNA transcript (Fig. 4). The outlier cell line, H23, had
the highest levels of total rRNA. A provisional conclusion, for
future exploration, is that the nc-rRNA and rRNA are functionally
linked in the majority of these lung cancer cells. By analogy to
their relationship in mouse fibroblasts [3,4], the nc-rRNA may be
a negative regulator of the rRNA. In the H23 outlier, other factors
may have added importance in rRNA regulation.
Site +139 SNP correlated inversely with nc-rRNA
We next inquired whether SNP +139, that occurred in most of
the cell lines and varied significantly among them, had a
relationship to nc-rRNA and total rRNA expression. The frequency
of the T to C genomic SNP at position +139 in the original panel of
six cancer cell lines had a significant negative rank correlation with
nc-rRNA (Fig. 5A). This association was investigated in more detail
by use of the whole panel of cell lines and the determination of SNP
allele frequencies in the expressed rRNA by pyrosequencing (see
Table2).WiththerRNAdataforallofthe celllines,therewasagain
a significant negativerank correlation between SNP+139 frequency
and nc-rRNA levels (Fig. 5B).
Secondary structure models of rRNA species
Stable secondary structure has been reported previously for the 59-
leader sequence of rRNA [8,9]. We considered whether the +139
SNP might alter the secondary structure, and hence the potential
functionality, of the rRNA transcript or of the nc-rRNA. We
modelled co-transcriptional folding of the leader sequence, +1t o
+414, using MPGAfold, including either U or C at site +139. There
were 5 major stem structures, which we have designated as shown in
Fig. 6. This overall structure was stable and conserved, giving the
same base-pairing pattern in 70 to 100% of runs, as illustrated by the
blue or magenta color coding in Fig. 6. The +139 site is located in a
long stem structure, termed the LL motif, made up of sequences
including +46 to +152 (extending as far as +38 to +166 in some
modelling outcomes).The characteristicsof the LL motif with U or C
at site +139 are compared in Table 3. The SNP form +139 was
consistently, if slightly, more stable, with a 22.7 kcal/mol advantage
in both best free energy and dominant free energy in the LL folds.
Two common local variants of the LL motif exist, one in which the
+139 site occurs in a 5-nucleotide stem next to a bulge, and another
where an unpaired +140 U next to +139 loops out (Fig. 6), for a 3-
loop-2 stem configuration. As the MPGAfold population levels
increased, thefrequencyof the better fitfinalstructurescontainingthe
3-loop-2 stem within the LL motif also increased, at the expense of
Table 2. Frequency of SNP +139 by cloning and by
pyrosequencing methods.
Cells
Number clones (percent of all
clones) with genomic SNP +139
Percent SNP +139 in rRNA
by pyrosequencing method
HPL 4 (7.8) 8.2
A549 28 (51.8) 25.2
H441 7 (19.4) 18.7
H23 7 (14.6) 8.5
H1792 0 7.8
H2030 3 (5.4) 5.2
H2122 2 (3.1) 11.4
H727 Not done 12.2
H1944 Not done 20.4
H1395 Not done 10.4
H2126 Not done 20.3
H2023 Not done 10.3
H1703 Not done 45.3
H1355 Not done 21.3
doi:10.1371/journal.pone.0007505.t002
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wild type +139 U and SNP +139 C, but the latter retained a higher
percentage of the 5-nucleotide conformation. The free energies of
both conformations of +139 C were slightly more favourable than
those of the +139 U conformations. This may well be related to
pairing of +139 C to the G at +63.
We also modelled the co-transcriptional folding of other lengths
of the 59-leader sequence (not shown). Among these was the +1t o
+173 length, to include the nucleolin binding site, the first known
site for specific protein interaction in the 59-leader. The sequence
+1t o+700 was studied in order to encompass a region
downstream of +414 known to affect leader cleavage [6] and
including a U3 binding site [10]. The SNP at +139 did not
significantly impact the folding of these sections of rRNA. Finally,
we used another program, Mfold, to examine the gross structural
characteristics of the large 59-external transcribed spacer (+1t o
Figure 2. RT-PCR products corresponding to nc-rRNA of the human rRNA gene promoter and upstream sequences. The products were
also confirmed by DNA sequencing. Representative findings are shown for cell lines HPL (immortalized non-transformed cells from human peripheral
lung epithelium) and A549, a human lung adenocarcinoma cell line. Results for controls omitting the RT enzyme are shown in the lower panels. The
positions amplified by specific primers are illustrated at the bottom of the figure, with +1 being the transcription start site for rRNA. The nc-rRNA was
detected between 21003 and +203, but not between 21772 and 21225.
doi:10.1371/journal.pone.0007505.g002
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long-distance interactions with the nucleotides outside the LL sub-
domain resulting from the presence or absence of the +139 SNP
(not shown). Mfold results also showed potential for the formation
of the same LL motif variants illustrated in Fig. 6 by the wild type
and the +139 SNP sequences.
In addition we examined the nc-rRNA, which extends from
about 21000 to at least +300.Its exact extent from the
transcription start site downstream could not be determined
because of overlap with the regular rRNA transcript. In all
MPGAfold runs modelling the nc-rRNA from 21000 to +414, the
LL motif was conserved and was not involved in interactions with
sequences upstream of the transcription start site (not shown).
Discussion
We report here that human epithelial cells, including lung
cancer cells, like mouse fibroblasts, express a non-coding RNA
from the intergenic region of the rRNA gene, and that a negative
regulatory role is possibly implied, since there was a negative
correlation between levels of the nc-rRNA and total rRNA in most
of the human lung adenocarcinoma cell lines studied.
Further, we observed an interesting relationship between an nc-
rRNA SNP and the nc-rRNA levels. The sequences of the multiple
copies of rRNA genes are conserved among individuals of a species
and within individuals, a phenomenon speculated to represent
concerted evolution driven by multiple mechanisms, including
intrachromosomal recombination and interchromosomal gene
conversion [5,11]. Some variations have been noted, especially
in evolutionarily less conserved regions and in the 28S component
of the gene [12,13]. These changes mostly involved gain or loss of
repetitive segments, although single nucleotide differences have
also been noted [14–16]. No functional significance has yet been
assigned to these differences in nuclear rRNA. However, several
maternally-inherited point mutations in mitochondrial rRNA
predispose children to ototoxicity of antibiotic aminoglycosides,
by an incompletely understood mechanism involving mitochon-
drial membrane permeability and apoptosis [17–19].
Figure 3. Average levels of nc-rRNA from 7 RT-PCR repeats (A) and 45S rRNAs from 9 repeats (B) in a series of transformed human
lung cancer cell lines compared to the non-cancerous HPL cell line. *P ,0.05, ** P,0.01, significantly different from non-transformed HPL
cells. For 45S rRNA, apparent increases were of borderline significance for H2122 (p=0.062) and for H441 (P=0.0595).
doi:10.1371/journal.pone.0007505.g003
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leader region, past site +139, and differences in the frequency of
+139 C among the cell lines correlated negatively with levels of nc-
rRNA. On the basis of these observations, we postulate that the
+139 C SNP has a negative regulatory effect on either the
transcription rate of the nc-rRNA, or on its stability, and that the
ncRNA in turn negatively regulates the rRNA.
In the mouse fibroblast cells studied by Mayer et al. [3,4], the
ncRNA expressed from the intergenic region of the rRNA gene
caused a decrease in rRNA transcription as a result of interaction
with the nucleolar remodelling complex and altered DNA and
histone methylation. Specifically, the sequence 2127 to 239 was
implicated [4]. Sequences downstream of the transcription start site
were not studied; whether these may operate by a comparable
mechanism will require further study. Non-coding RNA has been
implicated in control of gene expression by a variety of mechanisms
[reviewed in 20–22]. In at least two instances, it has been reported
that regulatory long non-coding RNA, initiated upstream, extends
across the transcription initiation site, as observed in our results.
These long nc-RNAs included an interfering transcript functioning
as a negative repressor of the human dihydrofolate reductase gene
[23], and a trans-promoter transcript activating the fructose-1,6-
bisphosphatase gene in fission yeast [24].
There has been one publication pointing to a functional
difference among SNPs in human rRNA [25]. In human HaCaT
keratinocytes in culture, SNPs were localized in the region
surrounding the transcription start site for rRNA. In chromatin
immunoprecipitation assays, frequencies of SNPs were significant-
ly different in rRNA gene regions immunoprecipitated with the
Upstream Binding Factor (UBF) or with PolI, vs that combined
with the transcription factor basonuclin. In the region 2101 to
252, overall SNP frequency was quite low in the rRNA gene
associated with UBF or PolI and significantly higher in the
basonuclin-associated rRNA. This region encompasses the 296
SNP in our study, which occurred in a high percentage of the
A549 clones. Lack of SNPs in the UBF-associated sequence is
notable, in view of the promiscuity of binding of UBF throughout
the rRNA gene and its regulatory regions [26]. It could be of
interest to determine whether increased basonuclin/UBF binding
ratio occurs in the A549 cell line. Basonuclin is expressed in
epithelial as well as germ cells [27] and is highly increased in basal
cell carcinoma of skin [28].
Further evidence for functional differences among rRNA gene
variants comes from a study in mice [29]. Seven variants were
identified based on restriction fragment length polymorphisms and
included two SNPs in the promoter region. Variant SNPs in the
59-ETS were utilized to examine expression in specific adult
mouse tissues by quantitative PCR. Three variants were
universally expressed (including one at different levels among
tissues), two were not detected in any tissue, and two were found
only in certain tissues. These results were consistent with earlier
cytological assays of silver staining of nucleolar-organizing regions
for different chromosomes in human cells: fibroblasts and
leukocytes varied with regard to which chromosome clusters of
rRNA genes were most active [30], and there were differences
among clusters in response to the stimulating effect of serum [31].
The nc-rRNA, expressed from the intergenic region in mouse
cells and interacting with the nucleolar remodelling complex, has
recently been termed pRNA (promoter RNA), and was predicted
by computer modelling to have a stable hairpin secondary
structure, as was the comparable sequence from the human rRNA
promoter [4]. When Mayer et al. [4] mutated tandem G-C pairs in
the pRNA (at base pairs corresponding to sites 259 to 261 and
2118 to 2120 in the primary sequence used by us), they observed
a major effect on secondary structure, elimination of a stem-loop
Figure 4. Correlation of averages levels of total 45S rRNA
(relative to HPL cells) with average levels of nc-rRNA (relative
to HPL cells) in human lung cancer lines. When outlier line H23
was omitted, the Spearman rank correlation coefficient rho=20.74,
P=0.0135 by the Spearman rank test.
doi:10.1371/journal.pone.0007505.g004
Figure 5. Correlation of average levels of nc-rRNA (relative to
HPL cells) with frequency of the SNP at +139. A. Correlation of the
genomic SNP determined by cloning in 6 human lung cancer cell lines,
A549, H441, H23, H1792, H2030, and H2122 (see Table 2) (Spearman
rank correlation coefficient, rho=20.89, P=0.0409, by the Spearman
rank test). B. Correlation of the SNP as variant rRNA transcript in 13
cancer lines (Spearman rank correlation coefficient, rho=20.71,
P=0.0137, by the Spearman rank test).
doi:10.1371/journal.pone.0007505.g005
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protein in the nucleolar remodelling complex. We checked
whether a comparable alteration in secondary structure might
accompany the +139 SNP. Computer modelling of the rRNA
structures indicated that site +139 is localized in a stable,
energetically favored stem structure we termed the LL motif.
Co-transcriptional modelling indicated that the +139 U to C SNP
had a relatively small but possibly significant effect on local
Figure 6. Dominant secondary structures predicted by MPGAfold for the +1t o+414 59-leader sequence of 45S rRNA. The stems are
color-coded (scale shown) based on their frequency of occurrence in the final structure among 20 runs at the population level of 128 K. Unpaired
bases are black. The basic structure at left was highly conserved and was as shown in all but 4/40 of the final predictions. The dashed boxes at right
showed alternative conformations of the LL motif surrounding the +139 site, which differ for the 5 nucleotides at 60–64 and 138–142. For the wild-
type, +139 U (bottom dashed box), the conformation of these nucleotides involved predominately a 3-nucleotide stem and a looped-out U at +140
(dark blue in the diagram). This LL motif variant was found in 80% (16/20) of the final structures, with E=2246.1 kcal/mol in all but one of these. The
LL motif structures with the 5 nucleotides in orange, all as part of the stem, were in the minority, 20% (4/20) of all solutions (see Table 3). The full
structure illustrated was identical for all but one of these, with E=2245.9 kcal/mol. By contrast, for the SNP +139 C (top dashed box) the two
conformations were presented in similar proportions, 45% as the 3-nucleotide stem (green), E=2248.8 kcal/mol, and 55% as the 5-nucleotide stem
(light blue), E=2248.4 kcal/mol.
doi:10.1371/journal.pone.0007505.g006
Table 3. Comparison of co-transcriptional models of the LL motif rRNA leader sequence (+1t o+414) with C vs U at SNP site +139.
Wild-type (+139 U) SNP (+139 C)
Population size
modelled % LL motif in conformation listed Free Energy (kcal/mol) % LL motif in conformation listed Free energy (kcal/mol)
5 nt stem 3 nt stem Best Dominant 5 nt stem 3 nt stem Best Dominant
16 K
a, 25 runs 92% 4% 2245.9 2245.9 84% 12% 2248.8 2248.4
64 K, 25 runs 44% 56% 2246.3 2246.1 80% 20% 2249.0 2248.8
128 K, 20 runs 20% 80% 2246.1 2246.1 55% 45% 2249.0 2248.8 (40%)
2248.4 (50%)
aWith the 16 K population, 1 run (4% of the outcomes) did not include either the 5 nt or the 3 nt stem structures.
doi:10.1371/journal.pone.0007505.t003
rRNA SNP and Non-Coding RNA
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(overall lower free energy) and increased frequency of a 5-nt stem
in place of a 3-nt stem. Whether this conformational difference
might affect functional interactions of the LL motif will require
further study.
Another possible explanation for the special effects of the site
+139 SNP may be found in the DNA context: this site is located in
a conserved core steroid response element, TGTTCT, for Class I
hormone receptors, including those for glucocorticoids, androgens,
mineralocorticoids, and progesterone. Change of T to C at site
+139, the third position in this element, would likely eliminate
hormone receptor binding: replacement of this T with A abolished
response to all class I hormone receptors [32]. Also possibly
relevant is the presence just downstream of +139, at +159 to +167,
of a binding element for nucleolin, a major growth regulatory,
RNA-binding protein [33,34].
In addition to the +139 T/C SNP, we discovered 11 other sites
where SNPs were found more frequently than expected by chance.
None of these occurred often enough for correlations with cellular
properties to be attempted. These SNPs might have functional
significance, or may just be at sites that are particularly tolerant of
altered sequence. Sequences in the region of the human rRNA gene
which regulate transcription include the essential core promoter,
approximately 245 to +18, which is essential for transcription, and
an upstream control element starting at approximately 2200,
including the critical To element at 2165 to 2175 [35,36]. No
SNPs occurred in any of our lung cell lines from 213 to 24;
changes in this region may not be functionally tolerated. We noted
SNP hotspots in the upstream control element, at 2181, 2104,
296, and 272. Hotspot 2104 is part of a binding site, TCGCGC,
for the members of the E2F transcription factor family. Complex
effects on rRNA transcription, both positive and negative, have been
ascribed to E2F1, E2F4, and E2F6, when studied in transfected
human lung adenocarcinoma H358 cells [37,38]. It is possible that
replacement of 2104 T with C reduces repressive effects or
enhances the induction effect of one or more E2F family members.
The polymorphisms at 296, all substituting a T for a C,
eliminated a CpG site, where methylation could occur. The
changes at 272, all substituting a C for a T, created a CpG site. In
a recent study with human HeLa cancer cells, 27 CpG sites in the
upstream control element and core promoter of rRNA were in
general highly methylated, but in DNA immunoprecipitated with
antibody to PolI these sites had reduced or absent methylation
[39]. This included site 296 and one at 275. Possibly the loss of
the 296 CpG could increase constitutive binding of PolI. This
would be of particular importance in A549 cells, where nearly half
of the clones showed this change. A comparative study of human
liver cancers vs normal matching liver, found in the cancers,
significant hypomethylation of all of the rRNA upstream CpG sites
between 2137 and 259, including 296 [40]. Also, in a DNase
footprint assay, site 296 was located between two regions
protected by UBF, and showed enhanced DNA cleavage [41].
It has also been noted that human and mouse external and
internal transcribed spacers have a higher percentage of AA and
GA dinucleotides, and a lower percentage of AT, CA, and TA
dinucleotides, than expected by chance [8]. These may have
special roles and might be expected to be conserved. Five of the
hotspot SNPs in our study resulted in gain or loss of one of these
five dinucleotide pairs. Of particular possible importance are the
seven A/G SNPs at +52, which convert a GA and an AT to
neutral GG and GT; and the nine G/A SNPs at +207, all in cell
line H23, resulting in the creation of a GA dinucleotide.
In summary, an nc-rRNA, encompassing the rRNA gene
transcription start site, was expressed in human lung adenocar-
cinoma cells and was negatively correlated with frequency of a T/
C SNP at site +139 in the leader sequence of the 59-ETS. For most
cell lines, the nc-rRNA was also negatively correlated with the
total 45S rRNA. Recently chemicals targeting transcription factors
for rRNA have shown promise for treatment of cancer [42,43].
Furthermore, possible reduced expression of rRNA in brain, due
to hypermethylation, was linked to risk of suicide [44]. Most
recently, it has been suggested that increased rRNA due to trisomy
of chromosome 21 contributes to Down’s syndrome [45]. Thus
variability in rRNA has relevance for several human health issues.
The functional significance of the SNP +139 requires further
study. It had a local effect on the predicted distribution of the
secondary structures, might alter binding of glucocorticoid
receptors, and could interact with a nearby nucleolin binding site.
There were also 11 additional SNP hotspots, some of which might
be of functional importance. Specific contributions of rRNA gene
variants deserve further study.
Materials and Methods
Human lung cell lines
HPL1D, a nontransformed immortalized cell line prepared from
peripheral human lung epithelium [46], was obtained from Drs. T.
Takahasi and A. Masuda. Human lung adenocarcinoma cell lines
were obtained from the American Type Culture Collection
(Manassas, VA) (A549, H23, H441, H727, H1355, H1395,
H1703, H1792, H1944, H2023, H2030, H2122 and H2126).
They were cultured in RPMI 1640 medium (Invitrogen, Carlsbad,
CA) supplemented with 10% fetal calf serum (Gemini Bio-Products,
Woodland,CA),4 mMglutamine, and100units/mL penicillinand
100 ug/mL streptomycin (Invitrogen), at 37uC, 7% carbon dioxide.
At confluence the cells’ media was changed and then changed again
the following day. Cells were harvested at 48 hrs post-confluence by
treatment with 0.05% trypsin/0.02% EDTA (Invitrogen) and
storedat270uforlateranalysis.Post-confluentcellswerechosenfor
study to maximize the comparability among the cell lines and to
mimic conditions in a tumor mass in vivo.
Preparation of DNA, PCR, cloning and dideoxy
sequencing
DNA was extracted using Easy-DNA kits (Invitrogen). A 50 ng
DNA aliquot was used for amplification with a PlatinumTaq PCR
kit (Invitrogen). The 2408 to +326 region of human 45S rRNA
(GenBank Accession AL592188) was amplified by PCR, using
forward primer: 59-gcgatcctttctggcgagtcc-39 (2408 to 2389) and
reverse primer: 59-gacgagaacgcctgacacgca-39 (+307 to +326). In
brief, amplification was carried out in a final 50 ml PCR mixture
containing 20 mM Tris-HCL (pH 8.0), 50 mM KCl, 1.5 mM
MgCl2, 0.2 mM deoxynucleotide triphosphates, 0.2 mM primers,
10% dimethyl sulfoxide, and 1.25 U PlatinumTaq polymerase.
PCR was performed with an initial denaturation at 94uC for 2 min
followed by 40 cycles of denaturation (94uC for 30 s), annealing
(67uC, 30 s), and extension (72uC, 1 min). Amplified products
were resolved by electrophoresis using 10% polyacrylamide gels
(Invitrogen) and specific amplification verified after ethidium
bromide (0.5 mg/ml) fluorescence staining and imaging analysis
(UVP Inc., Upland, CA).
Cloning was performed using a TOPO Cloning kit (Invitrogen)
to obtain individual sequence clones for Sanger’s dideoxy DNA
sequencing. In brief, approximately 1–2 ml of fresh PCR product
were used according to the manufacturer’s instructions. The
bacteria carrying plasmids of correct PCR product inserts were
positively selected in culture plates in the presence of ampicillin
and kanamycin antibiotics for 24 hrs. For each PCR sample,
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vector primers provided in the cloning kit, purified with GFX
DNA binding spin-columns (Amersham Pharmacia Biotech Inc.,
Piscataway, NJ), and sequenced by fluorescence-based dideoxy
sequencing with an ABI 373 Sequencer (Applied Biosystems,
Foster City, CA). SNPs were identified by a SNP Report program,
which was written in Paradox version 4 (Borland, Austin, TX). It
converts output from the GenBank ‘‘Blast 2 Sequences’’ online
alignment software (www.ncbi.nlm.nih.gov) to a manageable
database of identified sequence variants. The program also allows
users to generate various SNP reports, including type of base
change, its location, and frequency pertinent to categories (such as
cell line and cancer vs. non-cancer) specified by users. Blast2
alignment results from PCR clones compared with the wild-type
reference sequence were first saved as text files. Each text file was
given a specific clone number, cell line name, and date. Gap(s) in
the alignment, indicative of base change(s), were recognized and
subsequently assigned according to nucleotide type and location
by the SNP Report program.
RNA analysis
Total RNA was isolated with the Versagene RNA Purification
System (Gentra Systems, Minneapolis, MN) or RNeasy Mini kit
(Qiagen, Germantown, MD) according to the manufacturers’
protocols. DNase treatment was performed to remove residual
DNA from the RNA samples by use of the recombinant DNase I
as specified in the protocol supplied with the Ambion DNA-free
Kit (Applied Biosystems, Foster City, CA). The treated samples
were washed twice with diethyl pyrocarbonate (DEPC)-treated
water at 14,0006g in Microcon 50 spin columns (Millipore,
Bedford MA) and finally eluted in 40–50 uL of DEPC-treated
water. Total RNA was quantified spectrophotometrically at
260 nm and diluted to a working concentration of 50 ng/uL.
Primers for reverse transcription (RT) and for PCR were selected
using Oligo software, version 6 (Molecular Biology Insights, Cascade,
CO) and PSQ Assay Design (Biotage, Uppsala, Sweden). RT was
carried out using SuperScript III (Invitrogen) and gene-specific
primerstogeneratecDNAsaccordingtothemanufacturer’sprotocol.
The primer used for RT determination of a 59 rRNA external
transcribed spacer region, indicative of rRNA level, was
cgtctcgtctcgtctcac. Sequences assessed for nc-rRNA are shown in
Figure 2. Primers used for RT of these regions were: Region A,
aataacccggcggcccaaaa; Region B, ccctctggtcaaccccaggacacac; Re-
gion C, gcccgtgtctccagagcg; Region D, ccacggggactcggaaacgaatt;
Region E, cagcctctcccccacataaacctgc; Region F, gcgaaagcgaaaccgt-
gagtcga; Region G, agacacacggagaggcagaatgcg; Region H, agaag-
gaaacacagggaacgaaagagaaat; and Region I, gggtgggtcagagacccgga.
PCR primer pairs were: rRNA transcript, gcccgtcgtgctgccct/
gggcgggaacgacacacca; Region A, ccccctgcgtgtggcacg/aataacc-
cggcggccaaaa; Region B, cggccttcggtccctcgtgtg/ccctctggtcaaccccag-
gacacac; Region C, gcgatcctttctggcgagtc/gcccgtgtctccagagcg; Region
D, tgtgggggagaggctgtcgct/ccacggggactcggaaacgaatt; Region E, ggcc-
tcgggaagagcttctcgac/cagcctctcccccacataaacctgc; Region F, gcattctg-
cctctccgtgtgtctgc/gcgaaagcgaaaccgtgagtcga; Region G, ctctctttctgt-
ccttttttccttcgtgc/agacacacggagaggcagaatgcg; Region H, acatcgctcta-
taaagaagggatcgtcga/agaaggaaacacagggaacgaaagagaaat; and Region
I, ccccctgcgtgtggcacg/gggtgggtcagagacccgga for ncRNA.
Quantitative real-time polymerase reactions (qPCR) for rRNA
and for nc-rRNA region A were performed with the Chromo4
System (MJ Research, Waltham, MA). The qPCR 20 mL mixture
contained 0.5 mM gene-specific upper and lower primers, 10 mlo f
2X SYBR Green PCR Mix (Qiagen), and a 2 mL aliquot of
cDNA. Amplification was carried out at 95uC for 15 minutes
followed by cycling at 94uC for 15 seconds, 65uC for 20 seconds,
and 72uC for 30 seconds. The Ct values were obtained using the
Opticon Monitor 2 software (MJ Research). Amounts of PCR
products were estimated from the fluorescence intensity as 2
2Ct.
For determination of nc-rRNA upstream regions, the same
protocol was used for regions D and I as above. Two-step PCR
was performed with denaturation at 94uC for 15 seconds and
annealing/extension at 68uC for 90 seconds for the 7 remaining
regions. For regions F, G and H, additional two-step PCR
reactions were carried out with annealing/extension at 72uC for
45 seconds to exclude interference of amplification due to GC-rich
secondary structure.
It is customary to normalize RNA expression for genes of
interest to that of a housekeeping gene of non-variable expression,
and in fact rRNA is often used for this purpose. We tested a
number of genes, GAPDH, PSMB2, RPL32, and PPIB, evaluated
previously as internal controls for lung cells [47], but none of these
were useful due to large variations between cell lines and/or
between experiments (data not shown). Instead, we minimized the
potential for error due to loading and RT efficiency variations by
quantifying total RNA based on 2 or more repeated spectropho-
tometer measurements and by performing multiple (minimum of
3) RT-PCR runs. Reproducible data were obtained from these
repeated experiments.
The presence and relative amounts of SNP alleles in rRNA were
determined by pyrosequencing. rRNA was converted to cDNA as
described above, except that the total PCR cycle number was
limited to 30 to avoid product saturation, and different primers
were used, 59-biotinylated gacctgtcgctgggagaggttg and regular
agtggggacgctcggacg. To prepare the template for pyrosequencing,
biotinylated PCR products in a 10 mL aliquot were captured in
2 mL streptavidin-sepharose beads (Amersham Biosciences, Pisct-
away, NJ) mixed with 40 mL binding buffer (10 mM Tris-HCl,
2 M NaCl, 1 mM EDTA, and 0.1% Tween-20, pH 7.6) and
35 mL doubly distilled water. After denaturation in 0.2 M NaOH
and wash in 10 mM Tris-acetate, pH 7.6, the single-stranded
template was annealed with 3 pmol sequencing primer (tcggacg-
cacgagaga) in a buffer containing 20 mM Tris-acetate, pH 7.6,
with 2 mM magnesium diacetate. The rRNA transcript variant
quantification was performed in PSQ 96 HS System (Biotage)
using PyroMark MD software and PyroGold reagents.
Statistical methods
Data in this study were analyzed with both parametric and
nonparametric methods. The nonparametric runs test was used to
determine whether there were stretches of sequences in which the
frequencies of SNPs were higher (or lower) than predicted by
chance. Contingency table analyses were used to compare selective
SNPs between cancer and HPL1D non-transformed lines. Several
hypotheses were formulated to investigate the randomness of SNP
counts. Pearson chi-square tests were used to test for homogeneity
of counts across cell lines. To investigate whether SNPs were more
frequent in certain specific intervals or strata of sites than in the
complimentary strata, Poisson regression analyses with offset
parameters equal to the number of sites were performed so that
the SNP rates could be compared in the suspected hot spot
intervals to the rates in the complimentary intervals. To investigate
whether SNPs were more likely to occur at individual sites, tail
probabilities from the Poisson distribution were calculated to
determine if the number of occurrences were larger than expected
by chance. For analyses involving Poisson regression, we routinely
evaluated the assumptions underlying model fits and included
over-dispersion parameters when appropriate. With contingency
table analyses, asymptotic and exact methods were employed. In
all cases, probabilities extracted from exact methods were in
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results are reported. Comparisons of total rRNA and nc-rRNA to
HPL1D were conducted with independent t tests. Linear
regression and rank correlation analysis were utilized to determine
the relationship between nc-rRNA and total rRNA. All statistical
tests were two-sided. Probability values (P) less than 0.05 were
considered significant.
RNA secondary structure prediction
To predict the secondary structure of fragments of rRNA, we
used our massively parallel genetic algorithm, MPGAfold,
involving populations of thousands of structures [48–51]. MPGA-
fold is a stochastic algorithm, which tends to stress the most
significant RNA conformations among its solutions, including
biologically significant transient or intermediate structures [50,52–
55]. In brief, using the free energy of RNA secondary structures
for a given input sequence as the fitness function, the algorithm
evolves a population of RNA conformers by exchanging parts of
the conformers, inserting mutations in structural elements and
selecting the best fit individual conformations resulting from these
operations. The fitness of the dominant conformations increases
with size of the population, with the significant suboptimal
(transitional) conformations being best captured by the lower
population level runs. For the present analyses, results of folding
runs at populations of 16 K, 64 K, and 128 K were investigated.
We have also employed the ability of the algorithm to simulate co-
transcriptional folding, i.e. folding of an elongating sequence. In
this mode the folding structures evolve in a changing sequence
context and local and transitional motifs are more likely to form
and persist longer. Based on our experience with the algorithm
and the experimental data supporting its results in other studies
[50,52–55] we used the elongation rate of two nucleotides per
MPGAfold generation. The analysis of the folding predictions was
performed with StructureLab [56–58]. The long sequence +1t o
+3,655, corresponding to the entire rRNA 59-external transcribed
spacer, was modelled with Mfold [59,60]. The reference sequence,
GenBank accession entry AL592188, was used for these
operations.
Supporting Information
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